Dangerous Pharmaceuticals

Ozempic Lawsuits Centralized in MDL

Ozempic Lawsuits Centralized in MDL

As of February 2nd, the U.S. Judicial Panel on Multidistrict Litigation consolidated at least 55 lawsuits against drugmakers Novo Nordisk and Eli Lilly into a multidistrict litigation (MDL) concerning GLP-1 RAs (specifically, Ozempic and similar medications). Lawsuits will be centralized in the Eastern District of Pennsylvania under U.S. District Judge Gene E. K. Pratter.

Read More


Update on Zantac Lawsuits

Update on Zantac Lawsuits

In February 2020, the U.S. Judicial Panel on Multidistrict Litigation consolidated all of the Zantac lawsuits in the U.S. District Court for the Southern District of Florida under Judge Robin Rosenberg.

Read More


Zantac (Ranitidine) Recalled by FDA for Potential Cancer Link

Zantac (Ranitidine) Recalled by FDA for Potential Cancer Link

Once a best-selling drug for more than 60 million Americans experiencing heart burn, Zantac (ranitidine) has now been pulled from the US market after several third-party tests found unsafe levels of a contaminant known as N-nitrosodimethyalmine (NDMA).

FDA Requests Removal of Zantac

Read More


FDA Approves Boxed Warning on Xeljanz (Tofacitinib)

FDA Approves Boxed Warning on Xeljanz (Tofacitinib)

The US Food and Drug Administration approved new warnings about an increased risk of blood clots and of death with the 10 mg twice daily dose of tofacitinib (Xeljanz, Xeljanz XR), which is used in patients with ulcerative colitis.

This new warning, issued July 26, 2019, comes just a few months after the first warning issued February 25, 2019.

Read More


Blood Pressure Medication Recall Expanded

Blood Pressure Medication Recall Expanded

Torrent Pharmaceuticals is recalling an additional 36 lots of Losartan potassium tablets and 68 lots Losartan potassium/hydrochlorothiazide tablets. This is the fourth expansion of the original recall posted in December 2018 of blood pressure medications manufactured by the company.

Read More


Lawsuit Update: Proton Pump Inhibitor Heartburn Meds, Kidney Damage

Lawsuit Update: Proton Pump Inhibitor Heartburn Meds, Kidney Damage

A growing number of Proton Pump Inhibitor (PPI) lawsuits have been filed against the manufacturers of PPI medications. Plaintiffs allege that as a result of taking a PPI for gastric acid-related conditions, they have been diagnosed with kidney injuries including Acute Interstitial Nephritis (AIN), chronic kidney disease and renal failure.

Read More


Nexium, Prilosec & Prevacid May Cause Severe Kidney Problems

Nexium, Prilosec & Prevacid May Cause Severe Kidney Problems

One of the kidney problems caused by Proton Pump Inhibitors like Nexium, Prilosec, and Prevacid may be Acute Interstitial Nephritis. Acute Interstitial Nephritis (AIN) is characterized by inflammatory cells infiltrating the interstitium of the kidney and may lead to acute kidney failure. Delays in diagnosis and persistent use of the drug causing AIN (such as Nexium, Prilosec, or Prevacid), can cause Chronic Kidney Failure.

Read More


Is that “Purple Pill” Increasing Your Risk of Kidney Disease?

Is that “Purple Pill” Increasing Your Risk of Kidney Disease?

Nexium, Prevacid and Prilosec, some of the most prescribed medicines in the world, may increase your risk for kidney disease.

Read More


Contact Us Today for Help!

  • This field is for validation purposes and should be left unchanged.